Â鶹´«Ã½

Tag - biogen

 
Â鶹´«Ã½
Search
 
August 14, 2026
 

Home Delivery
Subscribe for more access

BIOGEN

Eisai's Alzheimer's drug Lecanemab, also known as Leqembi
JAPAN / Science & Health
Mar 25, 2026
Research team confirms safety of Alzheimer¡¯s drug Lecanemab
The research team examined data on the health status of 2,672 patients 28 weeks after the start of the treatment.
Lecanemab was developed by drugmakers Eisai of Japan and Biogen of the United States.
JAPAN / Science & Health
Nov 15, 2024
European agency switches to recommending new Alzheimer¡¯s drug
The committee judged that the efficacy of lecanemab outweighs the risk for some patients.
A scientist looks at brain scans of a patient suffering from Alzheimer's disease in Geneva in 2023.
WORLD / Science & Health
Sep 21, 2024
Revolution or mirage? Controversy surrounds new Alzheimer¡¯s drugs
For defenders, the drugs represent a real chance to fight the disease. For detractors, they are a disappointment after a long line of costly failures.
Tests for patients suffering from Alzheimer's disease. According to the Alzheimer's Association, the disease is estimated to affect more than 6 million Americans.
WORLD / Science & Health / FOCUS
Apr 24, 2024
Alzheimer¡¯s drug adoption in U.S. slowed by doctors¡¯ skepticism
There is an entrenched belief among some doctors that treating the memory-robbing disease is futile.
Japan Times
WORLD / Science & Health
Jun 19, 2023
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
Japan Times
JAPAN
Jan 30, 2023
Priority review status given to Alzheimer¡¯s drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.
Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer¡¯s
Japan has approved one of the world¡¯s first blood test kits to detect signs of Alzheimer¡¯s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer¡¯s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer¡¯s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer¡¯s drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug¡¯s trial success raises hope for Alzheimer¡¯s prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer¡¯s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer¡¯s by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer¡¯s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
BUSINESS
Apr 9, 2022
Â鶹´«Ã½ Eisai still seeking accelerated U.S. review of Alzheimer¡¯s drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer¡¯s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD
Sep 3, 2021
Lawmakers probe ¡®anomalies¡¯ in approval of Biogen Alzheimer¡¯s drug
The congressional inquiry adds to pressure on the U.S. agency charged with regulating products that account for one-fifth of consumer spending.
Japan Times
WORLD / Science & Health
Jul 29, 2021
Doctors blast Biogen Alzheimer approval as ¡®regulatory failure¡¯
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency¡¯s decision.
Japan Times
COMMENTARY / World
Jul 19, 2021
Latest U.S. Alzheimer¡¯s drug fix is a patch job
Most of the FDA¡¯s decisions don¡¯t receive national attention, which means they may not be rectified until substantial harm is done.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer¡¯s drug furor highlights U.S. health system¡¯s failures
The FDA didn¡¯t deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug ¡®accelerated approval.¡±
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer¡¯s drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer¡¯s, rather than proof that it slows progression of the disease.
Forty-five meters down, a diver races to record a fleeting moment of WWII history
Kingo Wakasa photographs the kamikaze plane wing section he discovered at the USS Emmons wreck site.
New ¡®Katsu Curry Index¡¯ aims to show how weak the yen really is
A CoCo Ichibanya curry house in Tokyo.
Mexican man arrested over attempt to smuggle some 200 lizards into Japan
Mexican alligator lizards seized by Tokyo Customs from a Mexican man who attempted to smuggle them into Japan on Saturday through Haneda Airport
Gut bacteria may be behind many of Â鶹´«Ã½ colorectal cancer cases
A Japanese research team found that a toxin produced by certain E. coli strains, colibactin, caused genetic mutations in nearly half of colorectal cancer cases studied
She is Russia¡¯s richest woman. Her business empire is going up in flames.
Tatyana Kim, the head and co-founder of Wildberries, speaks about Ukrainian drone attacks on the company's warehouses in the course of the Russia-Ukraine conflict, at an unidentified location, in this still image from a handout video released on July 31.
Forty-five meters down, a diver races to record a fleeting moment of WWII history
Kingo Wakasa photographs the kamikaze plane wing section he discovered at the USS Emmons wreck site.
Ikarigata closer to emulating older brother Fujinokawa than many think
The future Fujinokawa (third from left) and Ikarigata (right) compete against each other at ages 5 and 3, respectively.
Where do foreign residents in Japan want to die?
The Yokohama Foreign General Cemetery is one of the few cemeteries in Japan that allows burials, albeit with conditions for the deceased, including foreign nationality and permanent residency in Kanagawa Prefecture.
¡®Total whiplash¡¯: Foreign residents react to Â鶹´«Ã½ changing permanent residency rules
The entrance to the Tokyo Immigration Bureau in Minato Ward, Tokyo, in March. For some foreign residents of Japan, tightening measures for permanent residency have become one factor in a broader calculation over whether remaining in the country makes financial sense over the long term.
As Â鶹´«Ã½ concrete jungles sizzle, urban forestry offers an all-natural fix
People and birds find relief from the sun in Tokyo's Nakano Ward earlier this month. While experts agree that urban greening is crucial to mitigating the impact of climate change, trees are becoming even more scarce in Japanese cities.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo¡¯s Shinjuku Ward.
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯

Longform

Disaster relief workers Taichi Kato (left) and Seiji Yoshimura enter the collapsed living quarters at Kyuganji temple in Yatsushiro, Kumamoto Prefecture.
What Kumamoto revealed about Â鶹´«Ã½ earthquake readiness
By Alex K.T. Martin

SUSTAINABLE JAPAN

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER